Abstract
There is evidence suggesting that adaptive increases in GLUT4 and mitochondria in skeletal muscle occur in parallel. It has been reported that raising cytosolic Ca(2+) in myocytes induces increases in mitochondrial enzymes. In this study, we tested the hypothesis that an increase in cytosolic Ca(2+) induces an increase in GLUT4. We found that raising cytosolic Ca(2+) by exposing L6 myotubes to 5 mM caffeine for 3 h/day for 5 days induced increases in GLUT4 protein and in myocyte enhancer factor (MEF)2A and MEF2D, which are transcription factors involved in regulating GLUT4 expression. The caffeine-induced increases in GLUT4 and MEF2A and MEF2D were partially blocked by dantrolene, an inhibitor of sarcoplasmic reticulum Ca(2+) release, and completely blocked by KN93, an inhibitor of Ca(2+)-calmodulin-dependent protein kinase (CAMK). Caffeine also induced increases in MEF2A, MEF2D, and GLUT4 in rat epitrochlearis muscles incubated with caffeine in culture medium. 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR), which activates AMP-activated protein kinase (AMPK), also induced approximately twofold increases in GLUT4, MEF2A, and MEF2D in L6 myocytes. Our results provide evidence that increases in cytosolic Ca(2+) and activation of AMPK, both of which occur in exercising muscle, increase GLUT4 protein in myocytes and skeletal muscle. The data suggest that this effect of Ca(2+) is mediated by activation of CAMK and indicate that MEF2A and MEF2D are involved in this adaptive response.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
AMP-Activated Protein Kinase Kinases
-
Aminoimidazole Carboxamide / analogs & derivatives*
-
Aminoimidazole Carboxamide / pharmacology
-
Animals
-
Caffeine / pharmacology
-
Calcium / metabolism*
-
Calcium-Calmodulin-Dependent Protein Kinases / metabolism
-
Cells, Cultured
-
Cytosol / metabolism
-
DNA-Binding Proteins / metabolism
-
Glucose Transporter Type 1
-
Glucose Transporter Type 3
-
Glucose Transporter Type 4
-
Hypoglycemic Agents / pharmacology
-
MEF2 Transcription Factors
-
Male
-
Monosaccharide Transport Proteins / biosynthesis*
-
Monosaccharide Transport Proteins / metabolism
-
Muscle Fibers, Skeletal / cytology
-
Muscle Fibers, Skeletal / drug effects
-
Muscle Fibers, Skeletal / enzymology
-
Muscle Proteins*
-
Muscle, Skeletal / cytology
-
Muscle, Skeletal / enzymology*
-
Myogenic Regulatory Factors
-
Nerve Tissue Proteins*
-
Phosphodiesterase Inhibitors / pharmacology
-
Protein Kinases / metabolism*
-
Rats
-
Rats, Wistar
-
Ribonucleotides / pharmacology
-
Transcription Factors / metabolism
Substances
-
DNA-Binding Proteins
-
Glucose Transporter Type 1
-
Glucose Transporter Type 3
-
Glucose Transporter Type 4
-
Hypoglycemic Agents
-
MEF2 Transcription Factors
-
Monosaccharide Transport Proteins
-
Muscle Proteins
-
Myogenic Regulatory Factors
-
Nerve Tissue Proteins
-
Phosphodiesterase Inhibitors
-
Ribonucleotides
-
Slc2a3 protein, rat
-
Slc2a4 protein, rat
-
Transcription Factors
-
Aminoimidazole Carboxamide
-
Caffeine
-
Protein Kinases
-
Calcium-Calmodulin-Dependent Protein Kinases
-
AMP-Activated Protein Kinase Kinases
-
AICA ribonucleotide
-
Calcium